Quantcast

Posts related to ‘Pixantrone’

Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC)

Posted: May 10, 2012 at 4:14 pm

Cell Therapeutics, Inc. (NASDAQ: CTIC) is about as controversial of a biotech stock as there can be.  It often traded huge volume around drug approval or study news, and shares ...
Read Full Story »

BioWatch: Cell Therapeutics Versus FDA, Before ASCO (CTICD)

Posted: May 24, 2011 at 7:40 am

Cell Therapeutics, Inc. (NASDAQ: CTICD) has been very active since its recent 1-for-6 reverse stock split took place on May 16, 2011.  Its share volume has increased on all but ...
Read Full Story »